Browse by author
Lookup NU author(s): Dr Jonathan Catterall, Emeritus Professor Tim Cawston
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
The destruction of bone and cartilage is characteristic of the progression of musculoskeletal diseases. The present review discusses the developments made with two different classes of drugs, the bisphosphonates and matrix metalloproteinase inhibitors. Bisphosphonates have proven to be an effective and safe treatment for the prevention of bone loss, especially in osteoporotic disease, and may have a role in the treatment of arthritic diseases. The development of matrix metalloproteinase inhibitors and their role as potential therapies are also discussed, especially in the light of the disappointing human trials data so far published.
Author(s): Catterall JB, Cawston TE
Publication type: Review
Publication status: Published
Journal: Arthritis Research & Therapy
Year: 2003
Volume: 5
Issue: 1
Pages: 12-24
ISSN (print): 1478-6354
ISSN (electronic): 1478-6362
URL: http://dx.doi.org/10.1186/ar604
DOI: 10.1186/ar604
